Vesa Olkkonen, Finland
TBA TBA
Moderator of 1 Session
Session Type
Late breaker
Session Time
16:00 - 17:00
Session Evaluation
Option 1
[{"name":"LncRNA-mediated control of vascular senescence and atherosclerosis","mode":"playlist","public":true,"info":{"id":1622,"presentation":"LncRNA-mediated control of vascular senescence and atherosclerosis","session":"Late breaker session 2","presenter":"Mark W. Feinberg, United States of America","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/Mark Feinberg, MD - EAS20- 1622- LncRNA-mediated control of vascular senescence and atherosclerosis.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/Mark Feinberg, MD - EAS20- 1622- LncRNA-mediated control of vascular senescence and atherosclerosis.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/B1AB2959.jpg","data":[],"tracks":[]}]},{"name":"Clinical Utility of LPA Genetic Characterization for Primary Prevention of Atherosclerotic Cardiovascular Disease.","mode":"playlist","public":true,"info":{"id":1656,"presentation":"Clinical Utility of LPA Genetic Characterization for Primary Prevention of Atherosclerotic Cardiovascular Disease.","session":"Late breaker session 2","presenter":"Mark Trinder, Canada","photo":""},"playlist":[{"name":"Clinical Utility of LPA Genetic Characterization for Primary Prevention of Atherosclerotic Cardiovas","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/EAS20 - Mark Trinder - 1656.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/EAS20 - Mark Trinder - 1656.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/EFFEE6E2.jpg","data":[],"tracks":[]}]},{"name":"The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting","mode":"playlist","public":true,"info":{"id":1687,"presentation":"The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and Angiogenic Sprouting","session":"Late breaker session 2","presenter":"Josephine M. Tan, Netherlands","photo":""},"playlist":[{"name":"Josephine Tan - EAS20 - 1687 - The MARCH6-SQLE Axis Controls Endothelial Cholesterol Homeostasis and","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/1687.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/1687.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/91BAC951.jpg","data":[],"tracks":[]}]},{"name":"Alternating light-dark cycles, but not continuous light, aggravates atherosclerosis development in APOE*3-Leiden.CETP mice","mode":"playlist","public":true,"info":{"id":1613,"presentation":"Alternating light-dark cycles, but not continuous light, aggravates atherosclerosis development in APOE*3-Leiden.CETP mice","session":"Late breaker session 2","presenter":"Maaike Schilperoort, Netherlands","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/Maaike Schilperoort - EAS20 - ID 1613 - Alternating light-dark cycles, but not continuous light, aggravates atherosclerosis development in APOE3-Leiden.CETP mice.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/Maaike Schilperoort - EAS20 - ID 1613 - Alternating light-dark cycles, but not continuous light, aggravates atherosclerosis development in APOE3-Leiden.CETP mice.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/FC6FA942.jpg","data":[],"tracks":[]}]},{"name":"Live Q&A","mode":"playlist","public":true,"info":{"id":1769,"presentation":"Live Q&A","session":"Late breaker session 2","presenter":"Vesa Olkkonen, Finland, Mark W. Feinberg, United States of America, Paolo Zanoni, Switzerland, Mark Trinder, Canada, Josephine M. Tan, Netherlands, Maaike Schilperoort, Netherlands","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/Late breaker session 2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/Late breaker session 2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/477BE0DC.jpg","data":[],"tracks":[]}]}]
{"type":2,"code":"7E32Xi0r"}
[session]
[presentation]
[presenter]
Presenter of 1 Presentation
Live Q&A
Session Type
Late breaker
Session Time
16:00 - 17:00
Lecture Time
16:35 - 16:50
[{"name":"Live Q&A","mode":"playlist","public":true,"info":{"id":1769,"presentation":"Live Q&A","session":"Late breaker session 2","presenter":"Vesa Olkkonen, Finland, Mark W. Feinberg, United States of America, Paolo Zanoni, Switzerland, Mark Trinder, Canada, Josephine M. Tan, Netherlands, Maaike Schilperoort, Netherlands","photo":""},"playlist":[{"name":"","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/Late breaker session 2.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/eas20\/25\/Late breaker session 2.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/eas20\/25\/477BE0DC.jpg","data":[],"tracks":[]}]}]
{"provider":"CTI","provider_live":0,"type":1,"code":"aE22Xi0wv"}
[session]
[presentation]
[presenter]
Hide